Tested Applications
| Positive WB detected in | Raji cells, HeLa cells, HepG2 cells |
| Positive IHC detected in | human tonsillitis tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:600 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13718-1-AP targets SLC9A9 in WB, IHC, IF/ICC, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4660 Product name: Recombinant human SLC9A9 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 481-645 aa of BC035779 Sequence: TPMLTWLQIRVGVDLDENLKEDPSSQHQEANNLDKNMTKAESARLFRMWYSFDHKYLKPILTHSGPPLTTTLPEWCGPISRLLTSPQAYGEQLKEDDVECIVNQDELAINYQEQASSPCSPPARLGLDQKASPQTPGKENIYEGDLGLGGYELKLEQTLGQSQLN Predict reactive species |
| Full Name | solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
| Calculated Molecular Weight | 645 aa, 73 kDa |
| Observed Molecular Weight | 66-73 kDa |
| GenBank Accession Number | BC035779 |
| Gene Symbol | SLC9A9 |
| Gene ID (NCBI) | 285195 |
| RRID | AB_2189452 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8IVB4 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SLC9A9 antibody 13718-1-AP | Download protocol |
| IHC protocol for SLC9A9 antibody 13718-1-AP | Download protocol |
| WB protocol for SLC9A9 antibody 13718-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SLC9A9 Polyclonal antibody (Cat# 13718-1-AP) has 5 total citations. These appear in Cell Communication and Signaling, Cancer Cell International, Molecular Cancer Research, American Journal of Medical Genetics B, and Attention Deficit and Hyperactivity Disorders. The associated research fields span glioblastoma cell proliferation, colorectal cancer immune infiltration, endosomal acid regulation and tumor progression, autism spectrum disorder, and ADHD molecular mechanisms. Applications include WB, IHC, and CoIP.
| Species | Application | Title |
|---|---|---|
Cell Commun Signal MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells. | ||
Cancer Cell Int SLC9A9 links tumor immune infiltration to therapeutic response in colorectal cancer with emphasis on mismatch repair proficient subtype. | ||
Mol Cancer Res An Endosomal Acid-Regulatory Feedback System Rewires Cytosolic cAMP Metabolism and Drives Tumor Progression | ||
Am J Med Genet B Neuropsychiatr Genet Autism spectrum disorder traits in Slc9a9 knock-out mice. | ||
Atten Defic Hyperact Disord Effect of disease-associated SLC9A9 mutations on protein-protein interaction networks: implications for molecular mechanisms for ADHD and autism. |

















